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Abstract
BACKGROUND: Among the less invasive operations noted in recent years, laparoscopic gastrectomy (LG) for 
gastric cancer has become popular because of advances in surgical techniques. We have performed LG with D2 
lymphadenectomy for 515 cases of gastric cancer between April 2009 and November 2019 at military hospital 103. 
AIM: We aimed to presented the techniques and results of laparoscopic-assisted gastrectomy (LAG) for gastric 
cancer. 
METHODS: Of the 515 gastric malignancy cases, distal gastrectomy was performed in 402 cases, proximal 
gastrectomy in 37 cases, and total gastrectomy in 76 cases. In all the cases, D2 lymph node dissection was 
performed according to the general rule of the Japanese gastric cancer association 3rd.
RESULTS: Quicker recovery was observed in the LG cases than in the open cases. The post-operative complications 
with this technique were within a permissible range. There was a statistical difference that was seen in the survival 
outcomes after LAG for gastric cancer between the laparoscopic-assisted distant, proximal, and total gastrectomy.
CONCLUSION: The laparoscopic technique is not only less invasive but also relatively safe and curative compared 
with open gastrectomy for advanced gastric cancer.
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Introduction
Gastric cancer is the most malignant disease in 
gastrointestinal cancer. According to the global cancer 
statistics report in 2018, the fatal was 8.2%, which 
was the second highest and just behind lung cancer 
in both men and women [1]. Radical gastrectomy with 
lymphadenectomy is the most effective treatment, 
bringing life for the patient.
Laparoscopic gastrectomy (LG) was first 
performed by Kitano in 1991 for early gastric cancer. 
Up to the present many surgeons have done this 
technique [2], [3]. For advanced gastric cancer, 
gastrectomy with D2 lymph node dissection is considered 
the standard surgery. However, with laparoscopic-
assisted, surgeons suspect the radicalization of the 
method [4], [5]. Although among the less invasive 
operations noted in recent years, LG for gastric cancer 
with D2 lymph node dissection has become popular 
because of many advances in surgical techniques, 
the patient was less of pain, recovered quickly, and 
reducing days of post-operative [6], [7]. Many authors 
in the world have compared the results of laparoscopic-
assisted gastrectomy (LAG) with the same of open 
gastrectomy [8], [9].
We performed LG with D2 lymph node 
dissection for over 515 cases of gastric malignancies 
from April 2009 to November 2019. We would like to 
present our experiences and results.
Subjects and Methods
Patients selection
Patients diagnosed with gastric 
adenocarcinoma were performed LAG with D2 
lymphadenectomy from April 2009 to November 2019 at 
the Department of Abdominal Surgery, Military Hospital 
103. Pre-operative evaluation included gastroscopy and 
abdominal computed tomography (CT) scan. All of the 
tumors invasion was not T4b and  adenocarcinomas, 
based on the Japanese gastric cancer treatment 
guidelines, ver.3 [4].
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Exclusion criteria
(a) Patient did not agree to participate in 
this study; (b) patients with other malignant tumors; 
(c) patients with upper abdominal large operation 
history who cannot be fitted for LAG; (d) patients with 
gastric stump cancer and recurrent cancer; (e) and 
patients with a surgical risk greater than American 
society of anesthesiologists Grade III or patients with 
contraindications to laparoscopic surgery.
Methods
We enrolled 515 gastric cancer patients, 
who were LAG with D2 lymphadenectomy according 
to guidelines of Japanese gastric cancer association 
(JGCA) issued in 2011, reprinted was 2014 [10], [11] and 
treatment guidelines of Vietnamese Ministry of Health 
issued in 2013 for LG with D2 lymphadenectomy [12]. 
All of the patients were recorded after surgery and 
follow-up time. The accidents in surgery, post-operative 
complications, mortality, and cases of recurrence, 
metastases, and causes of death were recorded and 
confirmed.
Surgical procedure
The procedure is carried out under general 
anesthesia with endotracheal intubation and epidural 
analgesia. CO2 pneumoperitoneum is induced after 
insertion of the first 10 mm trocar at the umbilicus with 
a modified open technique. The patient lies on the 
table in the supine position, the legs apart with 45°, 
and both arms spread out. The position of the patient 
can be change turned right or left tilt, head high, or low, 
depending on the surgery [12].
The main surgeon stood on between the 
patient’s legs, the video laparoscope assistant stood 
on the right of the patient, the 2nd assistant stood on 
the left [13], [14] (Figure 1). Two screens were placed 
on both sides of the patient’s head to create favorable 
conditions for the surgeon and the assistants to observe 
during the surgery.
Location of trocar
•	 We used 5 trocars (Figure 2)
•	 The first trocar was 10 mm just below the navel 
for the camera
•	 The second trocar was 12 mm, on the left 
midclavicular line at the umbilicus
•	 The third trocar was 5 mm, on the right 
midclavicular line at the umbilicus
•	 The fourth trocar was 5 mm, on the right 
midclavicular line below the costal margin
•	 The fifth trocar was 5 mm, on the left mid-
axillary line below the costal margin.
Patient S
N
C
A
Figure 1: Positions of the patient and surgeon S: Surgeon; C: Camera; 
A: Assistant; N: Nurse
Handling of the resected specimen and 
description of histological findings
The specimens are opened along the greater 
curvature, cleaned, fixed, and examined the macroscopic 
type, location, size, and invasion of the tumor. 
Measurement of tumor size along the margin of mucosal 
lesion and the length of the proximal and distal resection 
margins were measured [4].
Figure 2: Trocar placement
After dissection of lymph nodes from the 
specimen, they were stated to a number according 
to the 3rd JGCA, examples of the macroscopic type, 
number of lymph nodes, and fixed in 15–20% formalin 
solution, sent to histopathology department [4].
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The results of the postoperation stage were 
classified according to JGCA 3rd [4].
Follow-up and treatment after surgery
Post-operative patients received adjuvant 
chemotherapy according to the Japanese gastric cancer 
treatment guidelines ver 4th [11].
Every 6 months, the patients were re-examined 
at outpatient clinics: Examination, weight, cancer blood 
test marker, endoscopic, X-ray, abdominal ultrasound, 
abdominal CT, and positron emission tomography/CT 
when suspecting recurrence, metastasis.
Statistical analysis
Descriptive measures were applied for 
quantitative variables. We used Student’s t-test for 
normal distribution and Mann–Whitney test for abnormal 
distribution. Two categorical variables were compared 
by the Chi-square test. All the tests in this study were 
2-tailed, and the statistical significance level of 0.05 
was determined. Data were stored and analyzed by 
IBM SPSS version 22.
Ethical statements
This study was started after being approved 
by the ethics committee of the Vietnam military medical 
university.
Results
Between April 2009 and November 2019, 515 
patients with gastric cancer underwent laparoscopic-
assisted D2 gastrectomy included 402 cases 
(78.05%) of laparoscopy-assisted distal gastrectomy 
(LADG), 76 (14.75%) of laparoscopy-assisted total 
gastrectomy (LATG), and 37 cases (7.18%) of 
laparoscopy-assisted proximal gastrectomy (LAPG). 
The study included 356 male patients (69.12%) and 
159 female patients (30.87%) with no statistically 
significant difference between groups. The clinical 
features of the study were presented in (Table 1). 
Body mass index in LAPG group is higher in LADG 
and LATG group, but there was no difference with 
p = 0.810.
D2 lymphadenectomy was always performed 
according to the lymph node classification of the JGCA 
ver. 4. The operative time in LATG was 245.3 ± 65.2 
min. The average lymph nodes were 27.8 ± 8.34 
lymph nodes, higher than the 2 remaining groups, 
the difference with p < 0.001. The size of the tumor, 
lymph node metastasis, and the stage of disease in 
the LAPG group were significantly different LADG and 
LATG group with p < 0.05. According to the 3rd, JGCA 
classification, LATG group (53.9%) was in stage III [10]. 
Most of the histopathological lesions were malignant 
neoplasm, and there was no difference in all three 
groups with p = 0.459.
The recovery results of postoperation are 
shown in Table 2. The time of defecation, light exercise 
on the bed in three groups were not different with 
p > 0.05. The duration of light feeding, removal of 
drainage, and post-operative days in the LATG group 
was significantly longer than the LADG and LAPG with 
p <0.05.
There were 7 cases of surgical accidents 
(1.35%), including bleeding, colon, and spleen injury 
in all three groups. Post-operative complications 
encountered 22 cases (4.27%), including duodenal 
fistula, bleeding, respiratory failure, bronchitis, gastric 
gangrene, anastomosis leakage, residual abscess, and 
wound infection. There was no difference in all three 
groups with p > 0.05. Post-operative deaths (0.745) 
include 2 cases of respiratory failure and 1 case of 
gastric necrosis in the LADG group.
There were significant differences in overall 
survival curve between the three groups, test Log Rank 
χ2 = 6.160 p = 0.013
Follow-up post-operative survival is shown in 
Table 3 and Figure 3. The median follow-up time in the 
LADG group was longer. The rate of survival information 
was higher, and there was a difference with p = 0.013, 
test Log-rank χ2 = 6.160
Table 1: Clinicopathological features laparoscopic-assisted gastrectomy with D2 lymph node dissection
Variables Laparoscopy-assisted distal 
gastrectomy (n = 402)
Laparoscopy-assisted proximal 
gastrectomy (n = 37)
Laparoscopy-assisted total 
gastrectomy (n = 76)
p
Clinicopathological features
Age (mean±SD, years) 58.7 ± 11.71 56.8 ± 8.42 56.3 ± 12.35 0.163
Gender(male/female) (356/159) 279/123 28/9 49/27 0.686
Body mass index (mean±SD), kg/m2 20.2 ± 1.87 20.6 ± 2.10 20.5 ± 1.98 0.810
Surgical outcomes
Time: (mean ± SD), min 187.5 ± 50.7 165.8 ± 45.8 245.3 ± 65.2 0.000
Retrieved lymph node: (number) 24.6 ± 7.12 16.7 ± 5.66 27.8 ± 8.34 0.000
Tumor characteristics
Size of tumor: (mean±SD) cm 4.3 ± 1.65 3.8 ± 1.55 4.5 ± 1.76 0.002
Depth of invasion T1/T2/T3/T4a 45/158/150/49 6/15/12/4 0/30/35/11 0.009
Histologic type
Pap/tub/muc/ring/poor 61/93/38/43/166 6/11/3/2/15 9/13/11/15/28 0.459
N stage: pN0/pN1/pN2/pN3 140/85/91/86 14/9/8/6 15/16/20/25 0.022
TNM stage: I/II/III 53/155/194 14/11/12 12/23/41 0.019
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Table 3: Follow-up survival
Results of follow-up Laparoscopy-
assisted distal 
gastrectomy  
(n = 402)
Laparoscopy-
assisted proximal 
gastrectomy  
(n = 37)
Laparoscopy-
assisted total 
gastrectomy  
(n = 76)
p
Time up survival (months) 77.1 ± 2.803 66.7 ± 6.457 60.3 ± 6.155 0.013
Managing alive (n, %) 251 (62.4) 24 (64.8) 39 (51.3) 0.151
Disease - free alive 236 22 37
Disease alive 15 2 2
Managing death (n, %) 137 (34.0) 11 (29.7) 34 (44.7) 0.156
Death for recurrence 125 10 31
Death not recurrence 12 1 3
Missing (n, %) 14 (3.48) 2 (5.40) 3 (3.94) 0.832
Discussion
This study investigated the results of LAG 
with D2 lymphadenectomy, including the outcome 
of the operation, long-term observation, operative 
complications, and the difficulties in surgery. We also 
assessed the early operative complications and initially 
recording far results, recurrence, and metastases.
Figure 3: Kaplan–Meier survival curves according to different type of 
gastrectomy
Since the LADG for early gastric cancer 
treatment was first reported in 1994, many surgeons and 
major medical centers have applied this technique [15]. 
The number of LG has been increasing rapidly and 
indicated for progressive gastric cancer [16]. Many studies 
have demonstrated that LAG has advantages over open 
surgery, such as less invasive, reduced pain, quick 
recovery, and shorter hospital stay [5], [17], [18], [19].
The patient was placed in the supine position, 
and both arms were extended, two legs create angles 
of 45°. The main surgeon stood between the patient’s 
legs, and the person holding the camera stood on the 
patient’s right side. The first assistant was on the left 
side and the scrub nurse was on the right side. Our 
position is different from some authors who arranged 
the main surgeon stood on the left, the person holding 
the camera stood between the legs of patients [2], [13]. 
Through 515 operations, we found convenient for 
surgical step, without changing the position of the 
surgeon. The surgical procedure is performed through 
6 main steps, similar to author Kitano’s 10 steps [2] and 
Tanimura’s 9 steps [7].
The operative time was longer in LATG than in 
LADG and LAPG due to the surgical process and wide 
lymphadenectomy. The operation for the first cases was 
still unfamiliar, but the latter cases gradually improved 
in terms of technique and shortening time equivalent to 
open surgery [20]. The lymphadenectomy of groups 3 
and 4 is easy because it is removed with the stomach 
and the entire greater omentum, lesser omentum to 
close the right esophageal cardia to remove Group 1, 
cut the right artery and left artery at the stump [21], [22]. 
Group 6 is easy to harvest [23]. The 14v group is 
located next to the mesenteric vein on the lower right 
edge of the pancreas so we must hustle the pancreatic 
capsule before removing this group [9]. Group 5, 8ª, 
and 12ª along the common hepatic artery to the upper 
edge of the hepatic peduncle so our experience hustle 
upper pancreatic capsule, remove 8ª group and lesser 
omentum close to the hilum of the liver [24]. Dissecting 
along the left of the common hepatic artery to remove 
lymph node 9 is located around the celiac artery, 
dredging and cutting the left gastric artery at the root 
and remove group 7 [25]. Moving to the left along the 
spleen artery to remove group 11p [26] and in case 
of total gastrectomy, going to the left pancreas’s tail 
to take off group 10. Lifting the stomach, then cutting 
Table 2: Intraoperative and post-operative characteristics
Variables Laparoscopy-assisted distal 
gastrectomy (n = 402)
Laparoscopy-assisted proximal 
gastrectomy (n = 37)
Laparoscopy-assisted total 
gastrectomy (n = 76)
p
First flatus time (h) 50.5 ± 8.53 48.7 ± 7.85 52.4 ± 9.97 0.125
Times to walking (days) 2.1 ± 0.41 1.9 ± 0.35 2.3 ± 0.45 0.078
Time to starting liquid diet (days) 3.1 ± 0.57 3.5 ± 0.85 4.1 ± 1.23 0.012
Removal of intraabdominal drains (days) 3.5 ± 0.68 5.0 ± 1.26 5.8 ± 1.45 0.000
Post-operative hospital stay (days) 7.2 ± 1.25 7.5 ± 1.34 8.3 ± 1.91 0.017
Complications in surgery 7 (1.35%) 4 (0.99%) 1(2.70%) 2(2.63%) 0.405
Bleeding 2 1 1
Injure of the colon 1 0 1
Injure of the spleen 1 0 0
Post-operative complication 17(4.22%) 2(5.40%) 3(3.94%) 0.934
Respiratory failure 2 0 0
Bronchopneumonia 2 0 0
Intraabdominal bleeding 1 0 1
Anastomosis bleeding 1 1 0
Duodenal stump leak 4 0 0
Anastomosis leak 1 0 1
Necrotic gastric remain 2 0 0
Residual abscess 2 0 0
Wound infection 2 1 1
Mortality 3(0.58%) 3(0.74%) 0(0%) 0(0%) 0.825
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short gastric bundles to remove the 4sa and group 2 of 
the left cardia [13].
The duodenum is cut by stapler under the pylorus 
2 cm in distal and total gastrectomy. The stapler is passed 
through the 12 mm trocar after removing the gastric 
sonde. Using a stapler in open surgery to cut and narrow 
the stomach before suturing with the jejunum [27]. Using a 
25 mm congenital diaphragmatic hernia circle anastomosis 
machine to connect the stomach to the esophagus in 
LAPG or connect the jejunum to the esophagus in LATG, 
then we use the Orvil connector through the mouth to the 
esophagus to connect [27].
Three groups had the same catastrophic 
accidents (1.35%) encountered with p > 0.05, usually 
was bleeding due to spleen injure, splenic rupture, and 
colon injure. At the end of the surgery, we placed drainage 
under the liver or spleen and follow-up complications and 
take them off from 3 to 6 days when the patient had flatus 
and had a light meal. The duration for taking off drainage 
in LATG was longer than the LADG due to jejunum-
esophagus anastomosis which was narrow and easily 
leakage [28]. Complications in 3 groups were 4.27%, 
including 4 cases of duodenal fistula, 2 cases of abscess, 
2 cases of respiratory failure, and 2 cases of gastric 
necrosis. Post-operative death was 3 cases (0.58%) both 
in the LADG. Two cases of deaths due to respiratory 
failure, both in elderly patients (male, 74, and 78-years-
old), associated with hypertension, 1 pyloric stenosis 
and 1 pre-operative anemia. One death due to gastric 
necrosis was related to nourishing anemia. Huscher et al. 
encountered 1 death (3.3%) due to respiratory failure [6], 
and Kim et al. had 1 death (0.1%) due to pneumonia [29].
Survival time was in Table 3 and Figure 3, the 
shortest follow-up time was 2 months, and the longest 
was 123 months, the median survival time of the three 
groups had different with p = 0.013. Nineteen cases 
(3.68%) had no information, 314 alive cases (60.97%) 
had information, of which 295 cases without the disease 
(57.28%). There were reports of deaths of 182 cases 
(35.32%) of which deaths from recurrent diseases were 
166 cases, and 16 cases of deaths due to other causes. 
The result is similar to with the author Huscher et al., 
the 5-year survival rate reached 58.9%, the recurrent 
rate was 37.9% [6]. According to Hamabe et al., the 
5-year survival rate was 94.4% in the laparoscopy 
group and 78.5% in the open surgery group [30]. Hiki 
et al. followed LAG for stage I gastric cancer showed 
no recurrence in 5 years, the overall survival rate was 
98.3%, and demonstrated the long-term outcome of 
stage I gastric cancer after LAG equivalent to open 
surgery [31]. According to Park et al., the 5-year survival 
rate for the entire laparoscopy groups Stage I, II, and 
III was 87.5%, 77.3%, and 34.8%, relatively [32]. Our 
results were lower than that of Honda M. due to patients 
with stage I gastric cancer, the overall 5-year survival 
rate was 97.1% [33].
In summary, a study of 515 patients advanced 
gastric cancer was LAG with D2 lymph nodes dissection, 
finding that it was technically feasible and safe. 
Technically can be done by the surgical team with high 
skill of laparoscopic surgery. The patients had less pain, 
faster recovery, and shorter post-operative hospital 
stays.
Follow-up survival of after surgery, there 
were 314 patients alive (60.97%), of which 295 cases 
were disease-free survival. There were 182 cases of 
death (35.33%), of which 166 cases of death were for 
recurrence and metastatic. There was a difference of 
survival time between LADG, laparoscopic-assisted 
pancreaticoduodenectomy, and LATG in this study.
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